174 related articles for article (PubMed ID: 10387894)
1. Keeping breast cancer at bay. Women at risk are asked to weigh the pros and cons of a prevention pill.
Brink S
US News World Rep; 1999 May; 126(21):76. PubMed ID: 10387894
[No Abstract] [Full Text] [Related]
2. Breast Cancer Prevention Trial shows major benefit, some risk.
Jpn J Clin Oncol; 1998 Jun; 28(6):417-8. PubMed ID: 9730162
[No Abstract] [Full Text] [Related]
3. Women's decision making about whether or not to use breast cancer chemoprevention.
Altschuler A; Somkin CP
Women Health; 2005; 41(2):81-95. PubMed ID: 16219589
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen and breast cancer prevention: what should you tell your patients?
Goel V
CMAJ; 1998 Jun; 158(12):1615-7. PubMed ID: 9645176
[No Abstract] [Full Text] [Related]
6. The current status of breast cancer chemoprevention: a star is born.
Morrow M; Jordan VC
J Surg Oncol; 2007 Jan; 95(1):4-5. PubMed ID: 17192883
[No Abstract] [Full Text] [Related]
7. Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.
Harv Womens Health Watch; 2002 Oct; 10(2):1-2. PubMed ID: 12393316
[No Abstract] [Full Text] [Related]
8. The cost effectiveness of tamoxifen in the prevention of breast cancer.
Noe LL; Becker RV; Gradishar WJ; Gore M; Trotter JP
Am J Manag Care; 1999 Jun; 5(6 Suppl):S389-406. PubMed ID: 10538851
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint.
Fabian C
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2210-2. PubMed ID: 18006909
[No Abstract] [Full Text] [Related]
10. DM effort seeks to improve outcomes through prevention, early detection of breast cancer.
Dis Manag Advis; 2000 Sep; 6(9):140-4, 132. PubMed ID: 11125466
[TBL] [Abstract][Full Text] [Related]
11. Long-term tamoxifen trial halted.
Marshall E
Science; 1995 Dec; 270(5242):1562. PubMed ID: 7502061
[No Abstract] [Full Text] [Related]
12. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.
Bober SL; Hoke LA; Duda RB; Regan MM; Tung NM
J Clin Oncol; 2004 Dec; 22(24):4951-7. PubMed ID: 15598980
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen and the breast cancer prevention trial: women helping women.
Healy BP
J Womens Health; 1998 Apr; 7(3):279-80. PubMed ID: 9580905
[No Abstract] [Full Text] [Related]
14. Acceptance of tamoxifen chemoprevention by physicians and women at risk.
McKay A; Latosinsky S; Martin W
Cancer; 2005 Jan; 103(1):209-10. PubMed ID: 15540238
[No Abstract] [Full Text] [Related]
15. Chemoprevention of breast cancer: recommendations and rationale.
Am Fam Physician; 2003 Mar; 67(6):1309-14. PubMed ID: 12674459
[No Abstract] [Full Text] [Related]
16. Tamoxifen in cancer therapy: minireview.
Novotny L; Rauko P; Vachálková A; Peterson-Biggs M
Neoplasma; 2000; 47(1):3-7. PubMed ID: 10870680
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen for breast-cancer prevention.
Caine GJ; Blann AD; Stonelake PS; Kehoe ST; Lip GY
Lancet; 2003 Jan; 361(9352):177-8; author reply 178. PubMed ID: 12531605
[No Abstract] [Full Text] [Related]
18. [First drug for prevention of breast cancer].
MMW Fortschr Med; 1999 Aug; 141(34):16. PubMed ID: 10766546
[No Abstract] [Full Text] [Related]
19. Chemoprevention of breast cancer: recommendations and rationale.
Berg AO;
Am J Nurs; 2003 May; 103(5):107, 109, 111, 113. PubMed ID: 12759615
[No Abstract] [Full Text] [Related]
20. Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point.
Jordan VC
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2207-9. PubMed ID: 18006908
[No Abstract] [Full Text] [Related]
[Next] [New Search]
